BETA DRUGS
Back to Balance Sheet
|
BETA DRUGS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹1.73 Cr | ₹1.55 Cr | ₹1.51 Cr | ₹1.77 Cr | ₹1.59 Cr |
What is the latest Contingent Liabilities ratio of BETA DRUGS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹1.73 Cr |
| Mar2024 | ₹1.55 Cr |
| Mar2023 | ₹1.51 Cr |
| Mar2022 | ₹1.77 Cr |
| Mar2021 | ₹1.59 Cr |
How is Contingent Liabilities of BETA DRUGS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.73 Cr | 11.84 | |
| Mar2024 | ₹1.55 Cr | 2.38 | |
| Mar2023 | ₹1.51 Cr | -14.74 | |
| Mar2022 | ₹1.77 Cr | 11.17 | |
| Mar2021 | ₹1.59 Cr | - | |
Compare Contingent Liabilities of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹2,627.1 Cr | 9.9% | 57.4% | 24.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | 9.9% |
57.4% |
24.6% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses